Another Amyloid-beta Blocker Fails to Halt Dementia

Verubecestat, an oral drug that blocks the production of amyloid- β, did not improve clinical ratings of dementia in patients with prodromal Alzheimer disease, according to atrial in theNew England Journal of Medicine.
Source: JAMA - Category: General Medicine Source Type: research